Ubiquitin protein ligase
From Proteopedia
(Difference between revisions)
Line 56: | Line 56: | ||
**[[2kiz]] – hUPL RING-H2 finger domain - NMR<br /> | **[[2kiz]] – hUPL RING-H2 finger domain - NMR<br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase Bre1''' | ||
+ | |||
+ | **[[5trb]] – hUPL RNF20 domain<br /> | ||
+ | **[[4r7e]] – hUPL RING domain<br /> | ||
*'''Ubiquitin protein ligase CHFR''' | *'''Ubiquitin protein ligase CHFR''' | ||
Line 64: | Line 69: | ||
*'''Ubiquitin protein ligase Cbl''' | *'''Ubiquitin protein ligase Cbl''' | ||
+ | **[[5j3x]] – hUPL (mutant)<br /> | ||
**[[2y1m]] – hUPL - human<br /> | **[[2y1m]] – hUPL - human<br /> | ||
**[[1d5f]] – hUPL catalytic domain <br /> | **[[1d5f]] – hUPL catalytic domain <br /> | ||
Line 84: | Line 90: | ||
**[[1c4z]] – hUPL catalytic domain + ubiquitin conjugating enzyme E2 <br /> | **[[1c4z]] – hUPL catalytic domain + ubiquitin conjugating enzyme E2 <br /> | ||
**[[4a49]] – hUPL residues 354-435 + ubiquitin conjugating enzyme E2 <br /> | **[[4a49]] – hUPL residues 354-435 + ubiquitin conjugating enzyme E2 <br /> | ||
+ | **[[5axi]] – mUPL-B TKB domain + cblin <br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase CHIP''' | ||
+ | |||
+ | **[[4kbq]] – hUPL TPR domain + Hsc70<br /> | ||
*'''Ubiquitin protein ligase CNOT4''' | *'''Ubiquitin protein ligase CNOT4''' | ||
**[[2cpi]] – mUPL RNA recognition motif - NMR <br /> | **[[2cpi]] – mUPL RNA recognition motif - NMR <br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase COP1 or RFWD2''' | ||
+ | |||
+ | **[[5igo]] – AtUPL + Trib1 peptide - ''Arabidopsis thaliana'' <br /> | ||
+ | **[[5igq]] – hUPL + Trib1 peptide <br /> | ||
+ | **[[5hqg]] – hUPL <br /> | ||
*'''Ubiquitin protein ligase DOA10''' | *'''Ubiquitin protein ligase DOA10''' | ||
Line 108: | Line 125: | ||
**[[2kr1]] – hUPL N terminal - NMR <br /> | **[[2kr1]] – hUPL N terminal - NMR <br /> | ||
**[[2ldr]] – hUPL helix-RING domain - NMR <br /> | **[[2ldr]] – hUPL helix-RING domain - NMR <br /> | ||
- | **[[2d9s]] – mUPL UBA domain | + | **[[2d9s]] – mUPL UBA domain - NMR<br /> |
*Ubiquitin protein ligase E3 complex | *Ubiquitin protein ligase E3 complex | ||
Line 156: | Line 173: | ||
**[[3g1n]] – hUPL catalytic domain <br /> | **[[3g1n]] – hUPL catalytic domain <br /> | ||
**[[3h1d]] – hUPL HECT domain (mutant)<br /> | **[[3h1d]] – hUPL HECT domain (mutant)<br /> | ||
+ | **[[2mul]] – hUPL UBM1 domain - NMR <br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase IPAH''' | ||
+ | |||
+ | **[[5b0n]], [[5bot]] – UPL LRR domain – ''Shigella flexneri'' <br /> | ||
*'''Ubiquitin protein ligase ITCHY''' | *'''Ubiquitin protein ligase ITCHY''' | ||
**[[2jo9]] – mUPL WW3 domain + Epstein-Barr virus peptide - NMR <br /> | **[[2jo9]] – mUPL WW3 domain + Epstein-Barr virus peptide - NMR <br /> | ||
+ | **[[5dws]], [[5cq2]], [[4rof]] – hUPL WW3 domain + TXNIP <br /> | ||
+ | **[[5dzd]] – hUPL WW4 domain + TXNIP <br /> | ||
**[[2joc]], [[2ysf]], [[2kyk]] – mUPL WW domain - NMR <br /> | **[[2joc]], [[2ysf]], [[2kyk]] – mUPL WW domain - NMR <br /> | ||
**[[3tug]] – hUPL HECT domain <br /> | **[[3tug]] – hUPL HECT domain <br /> | ||
+ | **[[5c7m]] – hUPL HECT domain + ubiquitin<br /> | ||
**[[2nq3]] – hUPL C2 domain <br /> | **[[2nq3]] – hUPL C2 domain <br /> | ||
**[[2dmv]] – mUPL WW2 domain - NMR <br /> | **[[2dmv]] – mUPL WW2 domain - NMR <br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase Listerin (Ltn1)''' | ||
+ | |||
+ | **[[5fg0]], [[5fg1]] – yUPL N-terminal domain <br /> | ||
*'''Ubiquitin protein ligase LNX''' | *'''Ubiquitin protein ligase LNX''' | ||
Line 170: | Line 199: | ||
**[[3b76]] – hUPL 3rd PDZ domain <br /> | **[[3b76]] – hUPL 3rd PDZ domain <br /> | ||
**[[3vqg]] – mUPL 2rd PDZ domain + peptide<br /> | **[[3vqg]] – mUPL 2rd PDZ domain + peptide<br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase LUBX''' | ||
+ | |||
+ | **[[4wz2]], [[4xi1]], [[4wz0]] – LpUPL (mutant) – ''Legionella pneumophila'' <br /> | ||
+ | **[[4wz3]] – LpUPL + E2<br /> | ||
*'''Ubiquitin protein ligase MDM2''' see [[MDM2]] | *'''Ubiquitin protein ligase MDM2''' see [[MDM2]] | ||
+ | |||
+ | *'''Ubiquitin protein ligase MIB1''' | ||
+ | |||
+ | **[[4tse]], [[4xi6]] – hUPL MIND BOMB domain <br /> | ||
+ | **[[4xi7]], [[4xib]] – hUPL MIND BOMB domain + peptide<br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase MID1''' | ||
+ | |||
+ | **[[5im8]] – hUPL COS domain - NMR <br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase MSL-2''' | ||
+ | |||
+ | **[[4rkg]], [[4rkh]] – DmUPL CXC domain + DNA - ''Drosophila melanogaster'' <br /> | ||
*'''Ubiquitin protein ligase MYCBP2''' | *'''Ubiquitin protein ligase MYCBP2''' | ||
Line 190: | Line 237: | ||
**[[2xbf]] – hUPL HECT domain <br /> | **[[2xbf]] – hUPL HECT domain <br /> | ||
**[[4be8]] – hUPL HECT domain (mutant) <br /> | **[[4be8]] – hUPL HECT domain (mutant) <br /> | ||
+ | **[[2n8s]] – rUPL WW1 domain – rat - NMR <br /> | ||
+ | **[[2n8u]] – rUPL WW2 domain - NMR <br /> | ||
+ | **[[5aht]] – rUPL WW3 domain - NMR <br /> | ||
*Ubiquitin protein ligase NEDD4 complex | *Ubiquitin protein ligase NEDD4 complex | ||
- | **[[1i5h]] – rUPL WW3 domain + amiloride-sensitive Na channel β subunit – | + | **[[1i5h]] – rUPL WW3 domain + amiloride-sensitive Na channel β subunit <br /> |
+ | **[[2n8t]] – rUPL WW2 domain + peptide - NMR <br /> | ||
**[[2ltx]], [[2lty]] – hUPL WW2 domain + peptide - NMR <br /> | **[[2ltx]], [[2lty]] – hUPL WW2 domain + peptide - NMR <br /> | ||
- | **[[2ez5]] – | + | **[[2ez5]] – DmUPL WW3 domain + COMM LPSY peptide - NMR <br /> |
**[[2kpz]], [[2kq0]], [[2laj]], [[2ltz]], [[2m3o]] – hUPL WW3 domain + peptide - NMR <br /> | **[[2kpz]], [[2kq0]], [[2laj]], [[2ltz]], [[2m3o]] – hUPL WW3 domain + peptide - NMR <br /> | ||
**[[4n7h]] – hUPL WW3 domain + arrestin peptide <br /> | **[[4n7h]] – hUPL WW3 domain + arrestin peptide <br /> | ||
Line 201: | Line 252: | ||
**[[3m7f]] – hUPL C2 domain + growth factor receptor bound protein<br /> | **[[3m7f]] – hUPL C2 domain + growth factor receptor bound protein<br /> | ||
**[[3jvz]], [[3jw0]] – hUPL HECT domain + ubiquitin + ubiquitin-conjugating enzyme<br /> | **[[3jvz]], [[3jw0]] – hUPL HECT domain + ubiquitin + ubiquitin-conjugating enzyme<br /> | ||
- | **[[2xbb]] – hUPL HECT domain + ubiquitin <br /> | + | **[[5c91]] – hUPL HECT domain + inhibitor <br /> |
+ | **[[2xbb]], [[5c7j]], [[5hpk]], [[5hpl]] – hUPL HECT domain + ubiquitin <br /> | ||
**[[4bbn]] – hUPL HECT domain (mutant) + polyubiquitin <br /> | **[[4bbn]] – hUPL HECT domain (mutant) + polyubiquitin <br /> | ||
Line 210: | Line 262: | ||
*'''Ubiquitin protein ligase PARKIN''' | *'''Ubiquitin protein ligase PARKIN''' | ||
- | **[[4k95]] – rUPL <br /> | + | **[[4k95]], [[4zyn]] – rUPL <br /> |
+ | **[[5c1z]], [[5c23]] – hUPL <br /> | ||
+ | **[[5c9v]] – hUPL (mutant)<br /> | ||
**[[2jmo]] – hUPL IBR domain - NMR <br /> | **[[2jmo]] – hUPL IBR domain - NMR <br /> | ||
**[[2zeq]] – hUPL ubiquitin-like domain <br /> | **[[2zeq]] – hUPL ubiquitin-like domain <br /> | ||
Line 218: | Line 272: | ||
**[[4k7d]] – rUPL C terminal domain <br /> | **[[4k7d]] – rUPL C terminal domain <br /> | ||
**[[2knb]] – rUPL + endophilin - NMR <br /> | **[[2knb]] – rUPL + endophilin - NMR <br /> | ||
+ | **[[5caw]] – UPL + ubiquitin – body louse<br /> | ||
*'''Ubiquitin protein ligase RAD18''' | *'''Ubiquitin protein ligase RAD18''' | ||
**[[2y43]] – hUPL RING domain <br /> | **[[2y43]] – hUPL RING domain <br /> | ||
+ | **[[2mrf]] – hUPL UBZ domain - NMR <br /> | ||
+ | **[[2mre]] – hUPL UBZ domain + ubiquitin - NMR <br /> | ||
*'''Ubiquitin protein ligase RBBP6''' | *'''Ubiquitin protein ligase RBBP6''' | ||
Line 232: | Line 289: | ||
**[[3rtr]], [[4f52]] – hUPL residues 5-108 + cullin-1 <br /> | **[[3rtr]], [[4f52]] – hUPL residues 5-108 + cullin-1 <br /> | ||
**[[4a0k]], [[4a0c]] – hUPL residues 12-108 + cullin-4B + cullin-associated NEDD8-dissociated protein<br /> | **[[4a0k]], [[4a0c]] – hUPL residues 12-108 + cullin-4B + cullin-associated NEDD8-dissociated protein<br /> | ||
+ | **[[4p5o]] – hUPL + cullin-1 + Ubc12 + DCN1-like protein<br /> | ||
**[[4a0l]] – hUPL residues 12-108 + cullin-4B + DNA damage-binding protein + DNA<br /> | **[[4a0l]] – hUPL residues 12-108 + cullin-4B + DNA damage-binding protein + DNA<br /> | ||
Line 241: | Line 299: | ||
**[[3gs2]] – hUPL C terminal + chromobox protein homolog<br /> | **[[3gs2]] – hUPL C terminal + chromobox protein homolog<br /> | ||
**[[3ixs]] – hUPL C terminal (mutant) + RING1 and YY1-binding protein<br /> | **[[3ixs]] – hUPL C terminal (mutant) + RING1 and YY1-binding protein<br /> | ||
- | **[[3rpg]] – hUPL + polycomb complex protein BMI-1 + E2 D3 <br /> | + | **[[3rpg]], [[4s3o]] – hUPL + polycomb complex protein BMI-1 + E2 D3 <br /> |
+ | **[[4r8p]] – hUPL + polycomb complex protein BMI-1 + histones + DNA <br /> | ||
*'''Ubiquitin protein ligase RNF''' | *'''Ubiquitin protein ligase RNF''' | ||
**[[4ppe]] – hUPL RING domain <br /> | **[[4ppe]] – hUPL RING domain <br /> | ||
- | **[[4ap4]] – hUPL 4 | + | **[[4ap4]], [[5ait]], [[5aiu]] – hUPL 4 RING domain + E2 + ubiquitin<br /> |
**[[2pie]] – hUPL 8 FHA domain <br /> | **[[2pie]] – hUPL 8 FHA domain <br /> | ||
**[[2csw]] – hUPL 8 FHA domain - NMR <br /> | **[[2csw]] – hUPL 8 FHA domain - NMR <br /> | ||
**[[4ayc]], [[4gb0]] – hUPL 8 RING domain <br /> | **[[4ayc]], [[4gb0]] – hUPL 8 RING domain <br /> | ||
**[[4orh]] – hUPL 8 residues 345-485 + E2 <br /> | **[[4orh]] – hUPL 8 residues 345-485 + E2 <br /> | ||
+ | **[[4whv]] – hUPL 8 residues 345-485 + ubiquitin + E2 <br /> | ||
+ | **[[5d1k]], [[5d1l]], [[5d1m]] – hUPL 25 residues 126-258 + E2 <br /> | ||
**[[4juy]], [[4oyj]], [[4p09]] – hUPL 31 PUB domain <br /> | **[[4juy]], [[4oyj]], [[4p09]] – hUPL 31 PUB domain <br /> | ||
**[[4ljq]] – hUPL 31 catalytic domain <br /> | **[[4ljq]] – hUPL 31 catalytic domain <br /> | ||
**[[4ljo]] – hUPL 31 catalytic domain + ubiquitin<br /> | **[[4ljo]] – hUPL 31 catalytic domain + ubiquitin<br /> | ||
+ | **[[5edv]] – hUPL 31 catalytic domain + ubiquitin + E2<br /> | ||
**[[4ljp]] – hUPL 31 catalytic domain (mutant) + ubiquitin<br /> | **[[4ljp]] – hUPL 31 catalytic domain (mutant) + ubiquitin<br /> | ||
**[[4owf]] – hUPL 31 catalytic domain + nf-κ-B modulator<br /> | **[[4owf]] – hUPL 31 catalytic domain + nf-κ-B modulator<br /> | ||
**[[4oyk]], [[4p0b]] – hUPL 31 PUB domain + otulin<br /> | **[[4oyk]], [[4p0b]] – hUPL 31 PUB domain + otulin<br /> | ||
**[[4p0a]] – hUPL 31 PUB domain + p97 peptide<br /> | **[[4p0a]] – hUPL 31 PUB domain + p97 peptide<br /> | ||
+ | **[[5ljn]] – hUPL 31 PUB domain + SPATA2 peptide<br /> | ||
+ | **[[4v3k]], [[4v3l]] – hUPL 38 reidues 439-515 + ubiquitin + E2<br /> | ||
**[[4kng]] – hUPL 43 PA domain + LGR5 + RSPO1<br /> | **[[4kng]] – hUPL 43 PA domain + LGR5 + RSPO1<br /> | ||
**[[2ma6]] – hUPL 123 RING domain - NMR<br /> | **[[2ma6]] – hUPL 123 RING domain - NMR<br /> | ||
+ | **[[5dka]] – hUPL 125 (mutant)<br /> | ||
+ | **[[2n9o]] – hUPL 126 N-terminal - NMR<br /> | ||
+ | **[[2n9p]] – hUPL 126 N-terminal + BAG6 ubiquitin-like domain - NMR<br /> | ||
**[[3icu]] – hUPL 128 protease-associated domain <br /> | **[[3icu]] – hUPL 128 protease-associated domain <br /> | ||
**[[3v3l]] – hUPL 146 WWE domain <br /> | **[[3v3l]] – hUPL 146 WWE domain <br /> | ||
**[[2rsf]] – mUPL 146 WWE domain + ATP<br /> | **[[2rsf]] – mUPL 146 WWE domain + ATP<br /> | ||
+ | **[[4qpl]] – mUPL 146 RING+WWE domains + E2<br /> | ||
**[[3l11]], [[4gb0]] – hUPL 168 RING domain <br /> | **[[3l11]], [[4gb0]] – hUPL 168 RING domain <br /> | ||
Line 273: | Line 341: | ||
**[[2m85]] – hUPL PHD domain - NMR<br /> | **[[2m85]] – hUPL PHD domain - NMR<br /> | ||
+ | **[[4qn1]] – hUPL residues 1000-1418<br /> | ||
*'''Ubiquitin protein ligase SIAH1''' | *'''Ubiquitin protein ligase SIAH1''' | ||
Line 280: | Line 349: | ||
**[[4i7b]], [[4i7d]] – hUPL C terminal + phyllopod peptide <br /> | **[[4i7b]], [[4i7d]] – hUPL C terminal + phyllopod peptide <br /> | ||
**[[4i7c]] – hUPL C terminal (mutant) + phyllopod peptide <br /> | **[[4i7c]] – hUPL C terminal (mutant) + phyllopod peptide <br /> | ||
- | **[[2an6]] – mUPL | + | **[[4x3g]] – hUPL SINA domain + peptide <br /> |
+ | **[[2an6]] – mUPL SINA domain + phyllopod peptide <br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase SIAH2''' | ||
+ | |||
+ | **[[5h9m]] – hUPL SBD domain <br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase SLRP''' | ||
+ | |||
+ | **[[4puf]] – SeUPL + thioredoxin - ''Salmonella enterica'' <br /> | ||
*'''Ubiquitin protein ligase SMURF''' | *'''Ubiquitin protein ligase SMURF''' | ||
Line 291: | Line 369: | ||
*'''Ubiquitin protein ligase SOPA''' | *'''Ubiquitin protein ligase SOPA''' | ||
- | **[[3sy2]] – SeUPL residues 165-782 + ubiquitin + ubiquitin-conjugating enzyme | + | **[[3sy2]] – SeUPL residues 165-782 + ubiquitin + ubiquitin-conjugating enzyme <br /> |
*'''Ubiquitin protein ligase SSPH1''' | *'''Ubiquitin protein ligase SSPH1''' | ||
Line 300: | Line 378: | ||
*'''Ubiquitin protein ligase TIR1''' | *'''Ubiquitin protein ligase TIR1''' | ||
- | **[[2p1q]] – AtUPL + auxin response protein + SKP1-like protein | + | **[[2p1q]] – AtUPL + auxin response protein + SKP1-like protein <br /> |
**[[2p1q]] – AtUPL + auxin response protein + SKP1-like protein + herbicide<br /> | **[[2p1q]] – AtUPL + auxin response protein + SKP1-like protein + herbicide<br /> | ||
Line 307: | Line 385: | ||
**[[3zo0]] – mUPL 21 residues 291-470 + IG γ-2A<br /> | **[[3zo0]] – mUPL 21 residues 291-470 + IG γ-2A<br /> | ||
**[[4b8e]] – mUPL 25 PRY-SPRY domain <br /> | **[[4b8e]] – mUPL 25 PRY-SPRY domain <br /> | ||
+ | **[[4cfg]] – hUPL 25 (mutant)<br /> | ||
+ | **[[5fey]] – hUPL 32<br /> | ||
**[[3u5m]] – hUPL 33 PHD+Bromo domains <br /> | **[[3u5m]] – hUPL 33 PHD+Bromo domains <br /> | ||
**[[3u5n]], [[3u5o]], [[3u5p]] – hUPL 33 PHD+Bromo domain + H3-histone peptide <br /> | **[[3u5n]], [[3u5o]], [[3u5p]] – hUPL 33 PHD+Bromo domain + H3-histone peptide <br /> | ||
Line 318: | Line 398: | ||
**[[3pt3]] – hUPL C terminal <br /> | **[[3pt3]] – hUPL C terminal <br /> | ||
**[[3ny3]] – hUPL UBR-box + N-degron<br /> | **[[3ny3]] – hUPL UBR-box + N-degron<br /> | ||
- | **[[3nih]], [[3nii]], [[3nij]], [[3nik]], [[3nil]], [[3nim]], [[3nin]] – yUPL UBR-box + peptide | + | **[[3nih]], [[3nii]], [[3nij]], [[3nik]], [[3nil]], [[3nim]], [[3nin]] – yUPL UBR-box + peptide <br /> |
**[[3nis]], [[3nit]] – yUPL UBR-box <br /> | **[[3nis]], [[3nit]] – yUPL UBR-box <br /> | ||
**[[3ntw]] – rUPL MLLE domain + peptide <br /> | **[[3ntw]] – rUPL MLLE domain + peptide <br /> | ||
Line 330: | Line 410: | ||
**[[3bi7]], [[2pb7]], [[2zkg]], [[3dwh]] – hUPL 1 SRA domain <br /> | **[[3bi7]], [[2pb7]], [[2zkg]], [[3dwh]] – hUPL 1 SRA domain <br /> | ||
**[[3oln]] – hUPL 2 SRA domain <br /> | **[[3oln]] – hUPL 2 SRA domain <br /> | ||
- | **[[3db4]] – hUPL 1 TUDOR domain <br /> | + | **[[3db4]], [[4qqd]] – hUPL 1 TUDOR domain <br /> |
**[[3fl2]] – hUPL 1 RING domain <br /> | **[[3fl2]] – hUPL 1 RING domain <br /> | ||
+ | **[[4tvr]] – hUPL 2 TUDOR + PHD domains <br /> | ||
+ | **[[5iay]] – hUPL 1 tandem TUDOR domains + spacer - NMR <br /> | ||
*Ubiquitin protein ligase UHRF complex | *Ubiquitin protein ligase UHRF complex | ||
Line 351: | Line 433: | ||
*Ubiquitin protein ligase XIAP BIR-1 domain | *Ubiquitin protein ligase XIAP BIR-1 domain | ||
- | **[[2poi]], [[2qra]] – hXIAP – human <BR /> | + | **[[2poi]], [[2qra]], [[4oxc]] – hXIAP – human <BR /> |
**[[2pop]] – hXIAP + TAB1 <BR /> | **[[2pop]] – hXIAP + TAB1 <BR /> | ||
Line 361: | Line 443: | ||
**[[1i3o]] – hXIAP (mutant) + caspase-3 <BR /> | **[[1i3o]] – hXIAP (mutant) + caspase-3 <BR /> | ||
**[[1i4o]], [[1kmc]], [[1i51]] – hXIAP + caspase-7 <BR /> | **[[1i4o]], [[1kmc]], [[1i51]] – hXIAP + caspase-7 <BR /> | ||
- | **[[4kmp]] - hXIAP + inhibitor<BR /> | + | **[[4kmp]], [[4wvs]], [[4wvt]], [[4wvu]] - hXIAP + inhibitor<BR /> |
**[[4kju]], [[4kjv]] - hXIAP (mutant) + inhibitor<BR /> | **[[4kju]], [[4kjv]] - hXIAP (mutant) + inhibitor<BR /> | ||
**[[3uw5]] – hXIAP residues 63-179 (mutant) + GDC0152 + inhibitor<br /> <BR /> | **[[3uw5]] – hXIAP residues 63-179 (mutant) + GDC0152 + inhibitor<br /> <BR /> | ||
Line 374: | Line 456: | ||
**[[1nw9]] – hXIAP + caspase-9 <BR /> | **[[1nw9]] – hXIAP + caspase-9 <BR /> | ||
**[[1tfq]], [[1tft]] – hXIAP + inhibitor - NMR <BR /> | **[[1tfq]], [[1tft]] – hXIAP + inhibitor - NMR <BR /> | ||
- | **[[3hl5]], [[4hy0]] – hXIAP + inhibitor <BR /> | + | **[[3hl5]], [[4hy0]], [[5c0k]], [[5c0l]], [[5c3h]], [[5c3k]], [[5c7a]], [[5c7b]], [[5c7c]], [[5c7d]], [[5c83]], [[5c84]] – hXIAP + inhibitor <BR /> |
**[[3uw4]] – hXIAP (mutant) + peptide + inhibitor <BR /> | **[[3uw4]] – hXIAP (mutant) + peptide + inhibitor <BR /> | ||
Line 394: | Line 476: | ||
**[[4cdj]] – mUPL ectodomain <br /> | **[[4cdj]] – mUPL ectodomain <br /> | ||
**[[4c99]], [[4c9a]], [[4c9e]], [[4c9r]], [[4c9u]], [[4cdk]] – mUPL ectodomain + R-spondin <br /> | **[[4c99]], [[4c9a]], [[4c9e]], [[4c9r]], [[4c9u]], [[4cdk]] – mUPL ectodomain + R-spondin <br /> | ||
+ | **[[4ufs]] – hUPL ectodomain + R-spondin + LGR5 <br /> | ||
*'''Ubiquitin protein ligase ZFP91''' | *'''Ubiquitin protein ligase ZFP91''' |
Revision as of 10:52, 4 December 2016
|
3D Structures of ubiquitin protein ligase
Updated on 04-December-2016
References
- ↑ Ardley HC, Robinson PA. E3 ubiquitin ligases. Essays Biochem. 2005;41:15-30. PMID:16250895 doi:http://dx.doi.org/10.1042/EB0410015
- ↑ Sakemi R, Yano H, Ogasawara S, Akiba J, Nakashima O, Fukahori S, Sata M, Kojiro M. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues. Oncol Rep. 2007 Jul;18(1):65-70. PMID:17549347
- ↑ Aguilar C, Lenoir C, Lambert N, Begue B, Brousse N, Canioni D, Berrebi D, Roy M, Gerart S, Chapel H, Schwerd T, Siproudhis L, Schappi M, Al-Ahmari A, Mori M, Yamaide A, Galicier L, Neven B, Routes J, Uhlig HH, Koletzko S, Patel S, Kanegane H, Picard C, Fischer A, Bensussan NC, Ruemmele F, Hugot JP, Latour S. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J Allergy Clin Immunol. 2014 Nov;134(5):1131-41.e9. doi:, 10.1016/j.jaci.2014.04.031. Epub 2014 Jun 15. PMID:24942515 doi:http://dx.doi.org/10.1016/j.jaci.2014.04.031
- ↑ Ardley HC, Robinson PA. The role of ubiquitin-protein ligases in neurodegenerative disease. Neurodegener Dis. 2004;1(2-3):71-87. PMID:16908979 doi:http://dx.doi.org/10.1159/000080048
- ↑ Stieglitz B, Rana RR, Koliopoulos MG, Morris-Davies AC, Schaeffer V, Christodoulou E, Howell S, Brown NR, Dikic I, Rittinger K. Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP. Nature. 2013 Oct 20. doi: 10.1038/nature12638. PMID:24141947 doi:http://dx.doi.org/10.1038/nature12638
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Tihitina Y Aytenfisu, Joel L. Sussman